T. Rowe Price Associates’s Mineralys Therapeutics MLYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$265K	Buy	19,568 +7,151	+58%	+$96.8K	﹤0.01%	2581
2025 Q1	$198K	Buy	12,417 +702	+6%	+$11.2K	﹤0.01%	2641
2024 Q4	$145K	Buy	+11,715	New	+$145K	﹤0.01%	2766